4//SEC Filing
Lydon Nicholas 4
Accession 0001415889-24-016982
CIK 0001597264other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 5:34 PM ET
Size
7.4 KB
Accession
0001415889-24-016982
Insider Transaction Report
Form 4
Lydon Nicholas
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-12+4,570→ 4,570 totalExercise: $106.14Exp: 2034-06-12→ Common Stock (4,570 underlying) - Award
Common Stock
2024-06-12+2,242→ 58,026 total
Footnotes (2)
- [F1]The reported transaction involved the Reporting Person's receipt of a grant of restricted stock units. The restricted stock units vest with respect to 100% of the shares underlying the restricted stock units on the earlier of (i) June 12, 2025 and (ii) the next annual meeting of the Issuer's stockholders. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]This option vests with respect to 100% of the shares underlying the option on the earlier of (i) June 12, 2025 and (ii) the next annual meeting of the Issuer's stockholders.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001639935
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 5:34 PM ET
- Size
- 7.4 KB